FuVeX's Public Investor Secured A Discount Before Its €3m Round

FuVeX announced an oversubscribed €3 million financing on 5 August 2026. Navarra's public investment company Sodena had already positioned itself for that moment through a €500,000 convertible instrument designed to enter the next professionally led round at a discount.

Sodena's board approved a 20% discount if the qualifying round closed in the first year and a 30% discount if it closed in the second or third. Its year-end loan disclosure then showed the full €500,000 outstanding at 31 December 2025.

The August round is the first publicly announced financing after the first anniversary of the board approval that names new professional investors, SEGO Venture and Izertis Ventures. That makes the 30% band the central economic question, but not a proven outcome. The legally relevant closing could have occurred earlier, and the original terms could have been amended or waived. No 2026 capital increase or conversion notice was visible in the Spanish official gazette index at the evidence cutoff.

For private-market readers, the distinction matters. Sodena is not only a public-policy sponsor sharing FuVeX's technology risk. Its approved instrument created a contractual route to receive more shares per euro than investors paying the next round price.

Sodena Approved A €500,000 Convertible Before The Round

The Sodena board minutes dated 29 July 2025 record a €300,000 convertible participating loan that could expand to €500,000. FuVeX's founders, related parties or small private investors had to provide at least a matching amount on the same terms. Sodena would match private commitments up to its €500,000 ceiling.

Sodena's loan transparency report for the fourth quarter of 2025 confirms that the approved ceiling was used. It records €500,000 granted to FuVeX Civil in 2025 and the same €500,000 outstanding at year-end.

That is stronger evidence than simply finding Sodena on an investor list. It identifies when the public money entered, how much remained outstanding and what event was meant to turn the loan into equity.

The Contractual Price Advantage Rises With Time

The conversion schedule rewards Sodena for committing before a professionally led round. The longer FuVeX took to reach that round, within the three-year window, the larger the discount became.

The final column translates the price discount into ownership economics. At a 20% discount, the same euro buys 25% more shares than at the round price. At a 30% discount, it buys about 43% more. Capitalised interest could add to the converting balance, although the available documents do not disclose the accrued amount.

This is a price advantage, not a guaranteed return. Its value depends on whether the conversion trigger was met, the final valuation, later dilution and FuVeX's performance. It also does not show how many shares Sodena ultimately received.

The €3m Round Is The Likely Test Event

Cinco Días reported that FuVeX closed an oversubscribed €3 million round with Sodena, SEGO Venture, Izertis Ventures and family offices linked to industry, agriculture and innovation. The company also reported future financing commitments and a €400,000 defence research grant from Spain's Centre for the Development of Industrial Technology.

The round arrived after a first €1.7 million Series A phase announced in October 2025. Contemporary coverage said Sodena led that phase with €500,000. The public chronology therefore contains two plausible conversion moments.

The December disclosure matters because it shows that the loan was still outstanding after the October announcement. It does not prove that no conversion happened later. The August announcement date falls just over one year after the board approval, which would point to the 30% band if the closing date and original trigger align. An announcement date, however, is not necessarily the legal completion date.

The safe conclusion is therefore specific: the contractual path existed, the €500,000 was outstanding at year-end, and the new round puts the path under scrutiny. A completed 30% conversion is not yet established.

Public Capital Carries Two Different Roles

Sodena is the Navarra government's financial instrument for supporting regional companies. In FuVeX, it was already a shareholder before approving the convertible. The July 2025 minutes state a 7.37% holding at that time.

The instrument adds a second role. Sodena supplied early capital on preferential future pricing while helping FuVeX reach the professional financing that could activate that pricing. Public support also extends beyond the convertible. Navarra's transparency portal records project awards to FuVeX Civil, while the latest round came with a separate €400,000 national defence research grant.

The layers should not be added into a single equity figure. Grants do not buy shares, the convertible's final equity allocation is undisclosed, and the €3 million headline is not broken down by investor.

Still, the structure changes the reading of the round. The state is not standing outside the cap table as a grant provider. It is simultaneously an existing shareholder, an early convertible lender and an industrial-policy sponsor. The new investors enter after that public capital helped bridge the company to a larger financing.

New Investors Enter A De-Risked But Unequal Price Setting

SEGO Venture and Izertis Ventures bring professional capital and strategic networks. Family offices add sector-linked money. FuVeX says the round will fund international growth, energy-grid inspection and dual-use applications in security and defence.

The company told Cinco Días that its aircraft had covered more than 36,000 kilometres of electricity lines under major commercial drone contracts for UFD, Naturgy's distributor, and Endesa. It also said first-half 2026 sales already equalled all of 2025. Those operating figures are company statements, but they explain why a professionally led round became possible.

For the new investors, Sodena's earlier terms are part of the effective financing price. If Sodena converts at a discount, the round-price investors absorb the dilution created by the extra shares issued per euro of public capital. That may be entirely rational compensation for Sodena's earlier risk and role in attracting matching funds. It is still an economic asymmetry that belongs in the round analysis.

The broader pattern resembles Dossaro's analysis of Neuraspace's state-funding disbursement gap: public support can reduce technical and financing risk without making private capital redundant. FuVeX adds a sharper pricing question because the public investor's early support carried an explicit conversion discount.

For register research, Spain's official gazette can confirm published corporate acts but not automatically reconstruct a current shareholder list. A Spain BORME research workflow is useful for watching for a capital increase or conversion notice while keeping the instrument terms separate from the eventual share allocation.

The Next Filing Must Show The Conversion Price

Three documents would resolve the economics: the 2026 capital increase deed, the subscription schedule and a Sodena disclosure of the conversion date and accrued interest. Together, they should show whether the October 2025 phase or the later €3 million round triggered conversion, which discount applied and how many shares Sodena received.

Until then, the public record supports a bounded but consequential finding. Navarra's investment company committed €500,000 before FuVeX's new professional investors arrived and negotiated a contractual route into their pricing at a 20% or 30% discount. The new round has made that preference economically relevant. The missing deed must show whether it became actual ownership.